Showing results (121-130 of 145) with videos related to
Sort By:
Pageof 15
Behavioural Pharmacology|April 26, 2000
Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administrationM B Hesselink, H Smolders, A G De Boer, et al.Pharmacology, Biochemistry, and Behavior|October 1, 1988
Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learningT Archer, W Danysz, A Fredriksson, et al.Neuropharmacology|July 1, 1995
Therapeutic brain concentration of the NMDA receptor antagonist amantadineJ Kornhuber, G Quack, W Danysz, et al.Neuroscience and Behavioral Physiology|July 17, 2010
Interaction of blockers of ionotropic NMDA receptors and metabotropic glutamate receptors in a working memory test in ratsY A Novitskaya, O A Dravolina, E E Zvartau, et al.Behavioural Pharmacology|July 15, 2004
The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in ratsE Zakharova, A Malyshkin, V Kashkin, et al.Amino Acids|January 1, 1999
Novel glycineB antagonists show neuroprotective activity in vivoG L Wenk, L M Baker, B Hauss-Wegrzyniak, et al.European Journal of Pharmacology|May 7, 1987
Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletionC Post, M L Persson, T Archer, et al.European Journal of Pharmacology|May 24, 2000
Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection intervalI V Belozertseva, O A Dravolina, O N Neznanova, et al.European Journal of Pharmacology|July 8, 1998
Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sitesG L Wenk, L M Baker, J D Stoehr, et al.Pharmacology & Toxicology|August 1, 1989
Adaptive changes in alpha-2 adrenoceptor mediated responses: analgesia, hypothermia and hypoactivityB G Minor, W Danysz, G Jonsson, et al.Pageof 15